Navigation Links
Folic Acid Doesn't Help the Heart
Date:5/6/2008

Long-term study, involving women, deals another blow to homocysteine theory

TUESDAY, May 6 (HealthDay News) -- Folic acid and vitamin B supplements aimed at reducing blood levels of the amino acid homocysteine did not protect women against heart disease and stroke, a long-term study found.

It's the latest of several trials to douse the hope that lowering homocysteine levels could reduce the incidence of cardiovascular disease, said study lead author Dr. JoAnn Manson, chief of preventive medicine at Harvard's Brigham and Women's Hospital in Boston.

"To our knowledge, this is the trial with the longest follow-up," Manson said. "And to date, it is the largest study of women."

The trial also included a large number of women without cardiovascular disease, she said. Most earlier studies concentrated on people who already had had a heart attack, stroke or other cardiovascular problem.

The new findings were published in the May 7 issue of the Journal of the American Medical Association.

The trial included more than 5,400 U.S. women who were health professionals. Some had a history of cardiovascular disease, and others had three or more coronary risk factors, such as high blood pressure, obesity or diabetes. Half of the women took a daily combination pill containing 2.5 milligrams of folic acid, 50 milligrams of vitamin B6, and 1 milligram of vitamin B12, while the other half took a placebo.

Over the next 7.3 years, 14.9 percent of the women taking the active pill had a cardiovascular event, such as a heart attack or stroke. The incidence of such events in the women taking the inactive pill was almost the same -- 14.3 percent.

There still are ongoing trials, all stimulated by past studies suggesting an association between high blood levels of homocysteine and cardiovascular disease. But the latest results "cast further doubt on the hypothesis that lowering homocysteine prev
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Womens Folic Acid Levels Improving
2. Folic Acid May Help Prevent Premature Birth
3. Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Womens Health Watch
4. Drug for cluster headaches may cause heart problems
5. Use of certain lipid measures not more effective in predicting coronary heart disease
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Urban Smog Tough on Young Adults Hearts
8. Stanford study highlights cost-effective method of lowering heart disease risks
9. Vitamin Es lack of heart benefit linked to dosage
10. Drug That Lowers Resting Heart Rate Being Tested
11. Heart Attack Boosts Diabetes Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... June 20, 2013 This ... focuses mainly on the oral and injectable ... report enumerates the various formulation technologies involved ... and advantages of specific technologies. Wherever possible, ... been discussed as proof of validation along ...
(Date:6/20/2013)... Beverly Hills, CA (PRWEB) June 20, 2013 ... David M. Amron, has been named by The Patient’s ... as an expert in liposuction, Dr. Amron will now ... Patient’s Guide. The Patient's Guide sees over one million ... provides information and articles related to plastic surgery and ...
(Date:6/20/2013)... Novatus Contract Management , the ... next release of upgrades and enhancements will be available ... system more robust, but continue to add investment value ... Online Negotiation Portal™ Interface enhancements – ... Portal from the outside. , Company Relationships ...
(Date:6/20/2013)... 20, 2013 Presenting at the ... society president and keynote speaker Dr. Rod ... future of rhinoplasty (plastic surgery of the nose) ... from across the nation. In his address, Dr. ... rhinoplasty to current open-technique rhinoplasty that reduces risk ...
(Date:6/20/2013)... weight may not reverse the damage that has been done ... even moderate weight loss can have a dramatic effect on ... within normal and healthy weight ranges is ideal, starting with ... shown to help relieve joint pain, as well as help ... have revealed that a weight loss of 11 pounds decreases ...
Breaking Medicine News(10 mins):Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 2Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 3Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 4Health News:Liposuction Guru, Dr. David Amron, Receives Award From The Patient’s Guide 2Health News:Novatus Contract Management Newest Enhancements and Upgrades to be Available July 1 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 3Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 4Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Diet Plans, Now Capable of Helping Patient’s Avoid The Risk of Arthritis With Natural Weight Loss 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Diet Plans, Now Capable of Helping Patient’s Avoid The Risk of Arthritis With Natural Weight Loss 3
... SPRING, Md., Feb. 28 Celebrity chef Emeril,Lagasse joins ... top,quality food with viewers this summer in the new ... 24/7 eco-lifestyle,television network, is set to launch in June ... premiering throughout the summer, including,EMERIL GREEN (wt) which will ...
... TDP-43 mutations expose potential therapeutic target, experts say , , ... a new, yet rare, genetic mutation in the development ... only exposes a potential therapeutic target for treating the ... mutation sets in motion the mechanism that causes many ...
... and men are completely satisfied with the time they spend ... study published in the Journal of Family Issues. , ... be more time pressured than those who work part time ... professor of sociology at Kent State University. , In ...
... will Integrate IDC,s X1590 into the First Standardized ... ... /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the global ... announced that Halifax Biomedical has selected,IDC,s X1590 as the DR ...
... PRINCETON, N.J., Feb. 28 Organizations,representing the state,s ... funding cuts proposed for hospital care for New ... $33 billion state spending plan for 2009, released,Tuesday, ... with funding of $608,million compared with current funding ...
... unlocked some of the mysteries of how the developing ... A present in the maternal blood stream. Their results ... Journal of Biological Chemistry. , The researchers studied ... formation of vitamin A stores in the body, during ...
Cached Medicine News:Health News:Emeril Lagasse and Planet Green Partner with Whole Foods Market(R) on Innovative New Series 2Health News:Emeril Lagasse and Planet Green Partner with Whole Foods Market(R) on Innovative New Series 3Health News:New Gene for Lou Gehrig's Disease Identified 2Health News:New Gene for Lou Gehrig's Disease Identified 3Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 3Health News:Hospital Groups United in Opposition to Charity Care Cuts 2Health News:Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development 2Health News:Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development 3
(Date:6/19/2013)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... of Medicine ( NEJM ) published results online ... Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients with ... (SLL). Ibrutinib was shown to be safe and effective ... patients who were at high-risk due to factors such ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Germany , is providing a deeper ... of developing type 1 diabetes (T1D), highlighting the importance ... The study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... in The Journal of the American Medical Association ...
(Date:6/19/2013)... June 19, 2013  Finesse Solutions, Inc, a ... sciences process applications, announced the launch of its ... cell culture and fermentation.  The 3L glass vessels ... of Finesse bioreactors and are designed to optimize ... are fully compatible with all Finesse G3Lab controllers, ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... Inc.,(Nasdaq: NVAX ) today announced that the Company ... the Phase I/IIa human clinical,trial of Novavax,s H5N1 pandemic ... August 26, 2008., The call will be hosted ... and other members of senior management, including,Chief Medical Officer, ...
... Johnson & Johnson Pharmaceutical,Research & Development, ... Food,and Drug Administration (FDA) requires additional information ... Application (NDA) for DORIBAX(TM),(doripenem for injection) for ... nosocomial pneumonia (NP), including ventilator-associated,pneumonia (VAP)., ...
Cached Medicine Technology:Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 3FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 4FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 5